CARsgen Therapeutics Holdings Ltd. (HK:2171) has released an update.
CARsgen Therapeutics Holdings Limited has announced a board meeting scheduled for August 28, 2024, to review and approve the interim financial results for the first half of the year. This key gathering will also address other unspecified business matters. The anticipation of the company’s mid-year performance figures is likely to interest shareholders and investors keen on gauging the company’s current financial health and future outlook.
For further insights into HK:2171 stock, check out TipRanks’ Stock Analysis page.
